IRIS
MERLINI, GIAMPAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.951
AS - Asia 13.837
EU - Europa 9.950
SA - Sud America 1.753
Continente sconosciuto - Info sul continente non disponibili 786
AF - Africa 489
OC - Oceania 29
AN - Antartide 1
Totale 45.796
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.487
CN - Cina 6.339
SG - Singapore 3.260
IE - Irlanda 2.557
HK - Hong Kong 1.500
BR - Brasile 1.284
VN - Vietnam 1.250
RU - Federazione Russa 1.157
FI - Finlandia 1.106
UA - Ucraina 1.079
DE - Germania 1.051
IT - Italia 772
FR - Francia 671
SE - Svezia 489
GB - Regno Unito 480
IN - India 331
ZA - Sudafrica 282
CA - Canada 221
BD - Bangladesh 218
AR - Argentina 155
MX - Messico 129
JP - Giappone 128
IQ - Iraq 112
TR - Turchia 95
PL - Polonia 84
NL - Olanda 79
CO - Colombia 77
PK - Pakistan 77
ES - Italia 75
BE - Belgio 72
ID - Indonesia 66
VE - Venezuela 64
EC - Ecuador 57
AT - Austria 52
PH - Filippine 49
SA - Arabia Saudita 48
UZ - Uzbekistan 44
MA - Marocco 43
CL - Cile 34
KE - Kenya 32
LT - Lituania 31
CZ - Repubblica Ceca 30
PY - Paraguay 30
IR - Iran 29
AE - Emirati Arabi Uniti 27
JM - Giamaica 27
JO - Giordania 26
MY - Malesia 26
IL - Israele 25
TN - Tunisia 22
AU - Australia 21
AL - Albania 19
KZ - Kazakistan 19
EG - Egitto 18
GR - Grecia 18
ET - Etiopia 17
MU - Mauritius 17
NP - Nepal 17
UY - Uruguay 17
BO - Bolivia 16
DZ - Algeria 16
PE - Perù 16
PT - Portogallo 16
AZ - Azerbaigian 14
DK - Danimarca 14
KG - Kirghizistan 14
KR - Corea 14
LB - Libano 13
NI - Nicaragua 13
CR - Costa Rica 12
LV - Lettonia 12
RO - Romania 12
TH - Thailandia 12
BG - Bulgaria 10
EU - Europa 10
HU - Ungheria 10
PA - Panama 10
PS - Palestinian Territory 9
HN - Honduras 8
HR - Croazia 8
OM - Oman 8
SY - Repubblica araba siriana 8
TT - Trinidad e Tobago 8
AM - Armenia 7
BB - Barbados 7
CH - Svizzera 7
NZ - Nuova Zelanda 7
SV - El Salvador 7
CY - Cipro 6
DO - Repubblica Dominicana 6
EE - Estonia 6
LK - Sri Lanka 6
NG - Nigeria 6
SN - Senegal 6
BH - Bahrain 5
GA - Gabon 5
MD - Moldavia 5
QA - Qatar 5
RS - Serbia 5
AO - Angola 4
Totale 44.925
Salva come PNG Salva come JPEG
Città #
Dublin 2.549
Chandler 2.425
San Jose 1.970
Ashburn 1.700
Singapore 1.611
Jacksonville 1.525
Hong Kong 1.464
Nanjing 1.319
Dallas 1.246
Beijing 1.031
Boardman 812
Nanchang 564
Council Bluffs 546
Princeton 522
Lawrence 488
Lauterbourg 471
Wilmington 471
Ho Chi Minh City 428
Los Angeles 422
Shenyang 403
Medford 397
Hebei 380
Helsinki 349
Changsha 343
Hanoi 312
Jiaxing 304
Ann Arbor 276
New York 255
Tianjin 248
Johannesburg 235
Hangzhou 223
Buffalo 219
Moscow 191
Redondo Beach 191
Munich 180
Santa Clara 175
Shanghai 163
Milan 144
Pavia 128
São Paulo 126
Woodbridge 111
Tokyo 109
Orem 104
Norwalk 101
Chicago 83
Da Nang 79
Frankfurt am Main 79
Turku 74
Toronto 71
Piscataway 69
Brussels 68
Warsaw 68
Chennai 65
Montreal 65
Verona 61
Brooklyn 60
Fairfield 60
London 60
Atlanta 59
Seattle 58
Denver 53
Guangzhou 53
Des Moines 49
Stockholm 48
The Dalles 48
Zhengzhou 48
Baghdad 47
Nuremberg 46
Ningbo 44
Washington 44
Houston 43
Rio de Janeiro 43
Haiphong 42
Mexico City 42
San Francisco 42
Falkenstein 41
Phoenix 40
Amsterdam 38
Tashkent 37
Manchester 36
Pune 36
Columbus 34
Boston 32
Rome 31
Hải Dương 30
Jinan 30
Ankara 28
Belo Horizonte 27
Biên Hòa 27
Charlotte 27
Kunming 27
Nairobi 27
Poplar 27
Brasília 26
Dhaka 26
Bologna 25
Curitiba 25
Mumbai 24
Vienna 24
Lahore 22
Totale 29.749
Salva come PNG Salva come JPEG
Nome #
Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview. 220
Prospective urinary albumin/creatinine ratio for diagnosis, staging, and organ response assessment in renal AL amyloidosis: Results from a large cohort of patients 217
Pharmacokinetic behavior of Rituximab: a study of different schedules of administration for heterogeneous clinical settings. 166
A novel method for proteomic analysis of immunoglobulin light chains and attribution to a germline gene-based family 164
A modified high-dose dexamethasone regimen for primary systemic amyloidosis 163
Fibrillazione atriale e amiloidosi cardiaca AL: un connubio intrigante 162
Liver biopsy discloses a new apolipoprotein AI hereditary amyloidosis in several unrelated Italian families 154
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis 154
Valore prognostico della presenza di bassi voltaggi elettrocardiografici nei pazienti affetti da amiloidosi AL 152
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 146
A novel AbetaPP mutation exclusively associated with cerebral amyloid angiopathy. 141
A modified high-dose dexamethasone regimen for primary systemic (AL) amyloidosis. 141
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 140
Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure. 139
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis 138
Functional correlates of N-terminal natriuretic peptide type B (NT-proBNP) response to therapy in cardiac light chain (AL) amyloidosis 138
Amyloid typing: immunoelectron microscopy 136
Advantages of the lognormal approach to determining reference change values for N-terminal propeptide B-type natriuretic peptide 136
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 135
A Strategy for Synthesis of Pathogenic Human Immunoglobulin Free Light Chains in E-coli 134
Interaction of the anthracycline 4'-iodo-4'-deoxydoxorubicin with amyloid fibrils:inhibition of amyloidogenesis. 134
AMICA: an electronic patient record specifically designed for an amyloidosis network 134
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis 133
Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure. 132
Beta2-microglobulin isoforms display an heterogeneous affinity for type I collagen. 131
Heavy chain disease can be detected by capillary zone electrophoresis. 131
Amyloidogenic light chains induce human cardiac fibroblast toxicity through alteration of mitochondrial functionality 131
AL amyloidosis. Characterization of amyloidogenic cells by anti-idiotypic monoclonal antibodies 129
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 129
A patient with AL amyloidosis with negative free light chain results 129
The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity 129
Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy 129
Acute phase proteins and prognosis in multiple myeloma. 129
AMYLOIDOSIS AL 128
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue. 128
Characterization of the two unique human anti-flavin monoclonal immunoglobulins. 128
Circulating free light chain measurement in the diagnosis, prognostic assessment and evaluation of response of AL amyloidosis: comparison of Freelite and N latex FLC assays 128
Reasoning with Effects of Clinical Guideline Actions Using OWL: AL Amyloidosis as a Case StudyKnowledge Representation for Health-Care 128
Amino acid sequence of k Sci, the Bence Jones protein isolated from a patient with light chain deposition disease. 127
A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis 127
A novel approach for the purification and proteomic analysis of pathogenic immunglobulin free light chains from serum 126
Obstructive intramural coronary amyloidosis: a distinct phenotype of cardiac amyloidosis that can cause acute heart failure. 125
Structural characterization of kappa II Inc, a new amyloid immunoglobulin 125
Bevacizumab treatment followed by maintenance in life-threatening POEMS syndrome. 125
Melphalan and dexamethasone with or without bortezomib in newly diagnosed AL amyloidosis: a matched case-control study on 174 patients 125
Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis 125
A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis 125
Amyloid Diseases at the Molecular Level: General Overview and Focus on AL Amyloidosis 125
Clotting alterations in primary systemic amyloidosis. 124
Cardiac light chain amyloidosis: The role of metal ions in oxidative stress and mitochondrial damage 124
4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters. 123
International prognostic scoring system for Waldenstrom macroglobulinemia 123
Autologous stem cell transplantation following heart transplantation for AL amyloidosis 123
ATR-FTIR spectroscopy supported by multivariate analysis for the characterization of adipose tissue aspirates from patients affected by systemic amyloidosis 123
Abnormalities in thrombin-antithrombin pathway in AL amyloidosis. 123
“Separation and quantification of two beta2-microglobulin isoforms”. 122
Waldenstrom macroglobulinemia 122
Analysis of Vlambda-Jlambda expression in plasma cells from primary (AL) amyloidosis and normal bone marrow identifies 3r (lambda III) as a new amyloid-associated germline gene segment 122
Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis 122
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis 122
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis 121
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis 121
Nutritional status evaluation of patients affected by al amyloidosis: a pilot study 120
Metodo per la separazione e la quantificazione di due conformazioni di beta-2-microglobulina in equilibrio dinamico 120
Hereditary amyloidosis 120
Cardiac immunocyte-derived (AL) amyloidosis: an endomyocardial biopsy study in 11 patients 120
Identification and quantification of urinary monoclonal proteins by capillary electrophoresis in AL amyloidosis 120
Bone marrow amyloidosis. 119
Clinical, radiological, and biochemical features of a bilateral buttock amyloidoma emerging after 27 years of hemodialysis. 119
4'-Iodo-4'-deoxydoxorubicin disrupts the fibrillar structure of transthyretin amyloid 119
A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis. 119
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 118
A practical approach to the diagnosis of systemic amyloidoses 118
Use of anti-(beta2 microglobulin) mAb to study formation of amyloid fibrils 117
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine 117
Patterns of relapse after upfront bortezomib therapy in AL amyloidosis 117
Effects of the Known Pathogenic Mutations on the Aggregation Pathway of the Amyloidogenic Peptide of Apolipoprotein A-I. 117
A prospective, controlled, non-randomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple myeloma. 116
Prognostication of survival and progression to dialysis in AA amyloidosis 116
Biochemical markers in early diagnosis and management of systemic amyloidoses 115
Treatment of patients with advanced cardiac AL amyloidosis with oral melphalan, dexamethasone, and thalidomide 114
Characterization of the new serum protein reference material ERM-DA470k/IFCC: value assignment by immunoassay. 114
Holter monitoring in AL amyloidosis: prognostic implications. 114
Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis 114
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: Avoiding misdiagnosis of a treatable hereditary neuropathy 114
Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial 113
Single-molecule real-time sequencing of the M protein: Toward personalized medicine in monoclonal gammopathies 112
In situ characterization of protein aggregates in human tissues affected by light chain amyloidosis: a FTIR microspectroscopy study 112
Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis 111
Salvage therapy with lenalidomide and dexamethasone in patients with advanced AL amyloidosis refractory to melphalan, bortezomib and thalidomide 111
Investigating heart-specific toxicity of amyloidogenic immunoglobulin light chains: A lesson from C. elegans 111
Dieta a contenuto controllato di proteine in pazienti affetti da amiloidosi AL con coinvolgimento renale 110
Biological variation of N-terminal pro-brain natriuretic peptide in healthy individuals. 110
Correlation between serum concentrations of N-terminal natriuretic peptide type B (NT-proBNP) and troponin-I (TnI) in AL amyloidosis 110
Diagnostic performance of triggering receptor expressed on myeloid cells-1 and CD64 index as markers of sepsis in preterm newborns 110
Prognostic validation of the international classification of immunoglobulin M gammopathies: A survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance? 110
Thalidomide plus intermediate-dose dexametasone is an effective but toxic treatment for patients with AL (primary) amyloydosis 110
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis 110
Comparison of three strategies for myocardial protection during coronary artery bypass graft surgery based on markers of cardiac damage. 109
Valore prognostico della presenza di disturbi della conduzione cardiaca nei pazienti affetti da amiloidosi AL 109
Totale 12.741
Salva come PNG Salva come JPEG
Categoria #
all - tutte 210.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 210.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.045 0 13 56 25 42 59 34 143 128 72 317 1.156
2022/20236.981 815 460 81 552 667 735 22 375 2.973 38 156 107
2023/20242.324 289 458 101 200 259 538 41 145 21 63 121 88
2024/20256.414 135 574 179 216 112 323 231 398 1.636 231 757 1.622
2025/202616.459 1.203 1.186 1.714 1.880 2.070 727 3.162 684 1.478 1.173 588 594
2026/20271.137 513 624 0 0 0 0 0 0 0 0 0 0
Totale 45.796